Tag: Phase 1b clinical study

February 15, 2019

Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL747 for Alzheimer’s Disease

Denali Therapeutics  (NASDAQ: DNLI) has announced the initiation of dosing in a Phase 1b clinical study of DNL747 in patients with...
March 29, 2017

Immunovaccine Announces Positive Data From New Study

Immunovaccine announced the first interim data from its still ongoing Phase 1b clinical study of DPX-Survivac, in combination with epacadostat...